5021 Everolimus (RAD001) in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab: a multicenter phase I clinical trial

2009 ◽  
Vol 7 (2) ◽  
pp. 267 ◽  
Author(s):  
S. Hurvitz ◽  
R. O'Regan ◽  
M. Campone ◽  
C. Manlius ◽  
L. Vittori ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Phase I Clinical Trial ◽  
Weekly Paclitaxel ◽  
Multicenter Phase ◽  
Her 2

scholarly journals A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

2015 ◽  
Vol 4 (7) ◽  
pp. 1051-1059 ◽  
Author(s):  
Pavani Chalasani ◽  
Marilyn Marron ◽  
Denise Roe ◽  
Kathryn Clarke ◽  
Maria Iannone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Phase I Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document